Abcellera Biologics Inc (ABCL)

$3.90 0.07 (1.76%)

16:00 EDT ABCL Stock Quote Delayed 30 Minutes

The 7 Best Penny Stocks to Buy in Q2 2024

By Matthew Farley, InvestorPlace Contributor Mar 27, 2024

Discover seven penny stocks to buy primed for significant gains in Q2 2024. Don't miss out on these picks or your portfolio could suffer.

3 Highly Rated Biotech Stocks to Buy for 300% Gains

AI Meets Biotech: 3 Top Stocks Transforming Medical Science

3 AI Stocks You’ll Regret Not Buying Soon

More Articles

Volume:

Previous Close -

Market Cap -

PE Ratio -

EPS -

Volume (Avg. Vol.) 1.60M

Day's Range $3.89 - $4.25

52-Week Range $3.79 - $8.05

Dividend & Yield N/A (N/A)

ABCL Stock Predictions, Articles, and Abcellera Biologics Inc News

From InvestorPlace
From the Web

Looking for Biotech AI Stocks? 3 Names That Will Benefit From the AI Boom

By John Blankenhorn, InvestorPlace Contributor Jul 8, 2023

AI is changing the face of biotechnology and drug discovery. Don't miss out on the next big boom in biotech, here are 3 stocks to consider.

7 Growth Stocks That Could Double Your Money in 2023

By Josh Enomoto, InvestorPlace Contributor May 14, 2023

For investors that really want to roll the dice, these are the enticing growth stocks that could double your money.

7 Stocks Under $10 That Analysts Love

By Josh Enomoto, InvestorPlace Contributor Apr 24, 2023

While these ideas might seem super cheap in a bad way, these stocks under $10 also rank among Wall Street analysts’ top picks.

7 Best Stocks Under $10 to Buy in April

By Josh Enomoto, InvestorPlace Contributor Apr 11, 2023

Although these stocks under $10 to buy may be cheap, their underlying businesses could yield significant upside.

7 Thrilling Biotech Stocks for Aggressive Investors to Buy

By Josh Enomoto, InvestorPlace Contributor Apr 5, 2023

Amid the noise of the global markets recently, these speculative biotech stocks to buy might trade with a mind of their own.

7 Stocks to Bet On if You Want to Be Richer Than Elon Musk

By Josh Enomoto, InvestorPlace Contributor Mar 22, 2023

If you can handle the heat of extreme speculation, you may want to throw some gambling funds at these stocks that can make you rich.

The 7 Most Undervalued Biotech Stocks to Buy in February 2023

By Josh Enomoto, InvestorPlace Contributor Feb 2, 2023

Get your hands on the latest medical innovations at a compelling discount with the most undervalued biotech stocks to buy.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

By William White, InvestorPlace Writer Sep 2, 2022

We're starting off the final trading day of the week with an overview of the biggest pre-market stock movers for Friday!

3 Biotech Stocks Under $10 to Add to Your Buy List

By Stavros Georgiadis, CFA, InvestorPlace Contributor Apr 26, 2022

These biotech stocks to buy are all profitable, which is important for investors looking to reduce their investment risk.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

By William White, InvestorPlace Writer Sep 17, 2021

There's only one day of trading left so let's start it off right with a look at the biggest pre-market stock movers for Friday.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

By William White, InvestorPlace Writer Jun 23, 2021

We're starting off the day with a look at the pre-market stock market movers for Wednesday with the biggest winners and losers.

Peter Thiel resigns from AbCellera board for personal reasons (NASDAQ:ABCL)

From Seeking Alpha Feb 23, 2024

AbCellera (ABCL) said Peter Thiel plans to resign from its board of directors for personal reasons, effective March 7. Read more here.

AbCellera Biologics (ABCL) Q4 2023 Earnings Call Transcript

From The Motley Fool Feb 21, 2024

ABCL earnings call for the period ending December 31, 2023.

AbCellera Biologics GAAP EPS of -$0.51 misses by $0.04, revenue of $38M misses by $0.13M (NASDAQ:ABCL)

From Seeking Alpha Feb 20, 2024

AbCellera Biologics reports disappointing FY 2023 results with missed EPS and revenue targets, but shows growth with new partner-initiated program starts.

4 Magnificent Healthcare Stocks to Buy in 2024 and Beyond

From The Motley Fool Jan 16, 2024

Healthcare stocks have underperformed in 2023, but that is expected to change this year.

3 Growth Stocks That Could Go Parabolic in 2024

From The Motley Fool Jan 15, 2024

These innovation-oriented companies could take flight this year.

AbCellera Biologics (ABCL) Q2 2023 Earnings Call Transcript

From The Motley Fool Aug 4, 2023

ABCL earnings call for the period ending June 30, 2023.

ADVERTISEMENT